|
|
Companies engaged in research or technology development with potential applicability to
cancer are encouraged to collaborate with National Cancer Institute (NCI) scientists (intramural) and
funded investigators (extramural). To learn how to find NCI and extramural scientists engaged in a particular field of interest, visit:
NCI can be a particularly good partner for companies seeking to commercialize new
diagnostic and therapeutic products. Its extensive infrastructure and expertise in
preclinical research and discovery and clinical trials offers mutually beneficial,
flexible, and innovative avenues for collaboration. To learn more, visit:
|
